Williams BW - Search Results

1

SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumours.

Khatri A, Williams BW, Fisher J, Brundage RC, Gurvich VJ, Lis LG, Skubitz KM, Dudek AZ, Greeno EW, Kratzke RA, Lamba JK, Kirstein MN. Khatri A, et al. Among authors: williams bw. Br J Cancer. 2014 Jan 21;110(2):304-12. doi: 10.1038/bjc.2013.738. Epub 2013 Dec 3. Br J Cancer. 2014. PMID: 24300978 Free PMC article.

2

Pharmacodynamic characterization of gemcitabine cytotoxicity in an in vitro cell culture bioreactor system.

Kirstein MN, Brundage RC, Moore MM, Williams BW, Hillman LA, Dagit JW, Fisher JE, Marker PH, Kratzke RA, Yee D. Kirstein MN, et al. Among authors: williams bw. Cancer Chemother Pharmacol. 2008 Feb;61(2):291-9. doi: 10.1007/s00280-007-0474-z. Epub 2007 Apr 12. Cancer Chemother Pharmacol. 2008. PMID: 17429628

3

Cap-dependent translation blockade and fixed dose-rate gemcitabine: interaction in an in vitro bioreactor system.

Williams BW, Chang JJ, Chi RM, Marker PH, Frethem CD, Le CT, Kratzke RA, Kirstein MN. Williams BW, et al. Cancer Lett. 2009 Oct 18;284(1):37-46. doi: 10.1016/j.canlet.2009.04.006. Epub 2009 May 12. Cancer Lett. 2009. PMID: 19442436

4

Combinatorial pharmacologic effects of gemcitabine and its metabolite dFdU.

Benyumov A, Gurvich VJ, Lis LG, Williams BW, Kirstein MN. Benyumov A, et al. Among authors: williams bw. ChemMedChem. 2011 Mar 7;6(3):457-64. doi: 10.1002/cmdc.201000447. Epub 2011 Jan 30. ChemMedChem. 2011. PMID: 21280228

5

Short versus continuous gemcitabine treatment of non-small cell lung cancer in an in vitro cell culture bioreactor system.

Kirstein MN, Wieman KM, Williams BW, Fisher JE, Marker PH, Le CT, Yee D, Kratzke RA. Kirstein MN, et al. Among authors: williams bw. Lung Cancer. 2007 Nov;58(2):196-204. doi: 10.1016/j.lungcan.2007.06.005. Epub 2007 Jul 25. Lung Cancer. 2007. PMID: 17651859

6

Pharmacodynamic modeling of sequence-dependent antitumor activity of insulin-like growth factor blockade and gemcitabine.

Khatri A, Brundage RC, Hull JM, Williams BW, Yee D, Kirstein MN. Khatri A, et al. Among authors: williams bw. AAPS J. 2012 Mar;14(1):1-9. doi: 10.1208/s12248-011-9308-3. Epub 2011 Nov 19. AAPS J. 2012. PMID: 22101930 Free PMC article.

7

Exposure-response relationships for oxaliplatin-treated colon cancer cells.

Kirstein MN, Root SA, Moore MM, Wieman KM, Williams BW, Jacobson PA, Marker PH, Tuttle TM. Kirstein MN, et al. Among authors: williams bw. Anticancer Drugs. 2008 Jan;19(1):37-44. doi: 10.1097/CAD.0b013e3282f07791. Anticancer Drugs. 2008. PMID: 18043128

8

Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cells.

Dings RP, Williams BW, Song CW, Griffioen AW, Mayo KH, Griffin RJ. Dings RP, et al. Among authors: williams bw. Int J Cancer. 2005 Jun 10;115(2):312-9. doi: 10.1002/ijc.20850. Int J Cancer. 2005. PMID: 15688384

9

Enhancement of tumor thermal therapy using gold nanoparticle-assisted tumor necrosis factor-alpha delivery.

Visaria RK, Griffin RJ, Williams BW, Ebbini ES, Paciotti GF, Song CW, Bischof JC. Visaria RK, et al. Among authors: williams bw. Mol Cancer Ther. 2006 Apr;5(4):1014-20. doi: 10.1158/1535-7163.MCT-05-0381. Mol Cancer Ther. 2006. PMID: 16648573

10

Heat-induced up-regulation of NAD(P)H:quinone oxidoreductase potentiates anticancer effects of beta-lapachone.

Park HJ, Choi EK, Choi J, Ahn KJ, Kim EJ, Ji IM, Kook YH, Ahn SD, Williams B, Griffin R, Boothman DA, Lee CK, Song CW. Park HJ, et al. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8866-71. doi: 10.1158/1078-0432.CCR-05-0818. Clin Cancer Res. 2005. PMID: 16361576

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters